IDEAYA Biosciences, Inc. IDYA Increase Decrease In Contract With Customer Asset And Liabilities
Increase Decrease In Contract With Customer Asset And Liabilities at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept idya:IncreaseDecreaseInContractWithCustomerAssetAndLiabilities.
The official record: IDEAYA Biosciences, Inc.’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEAYA Biosciences, Inc.'s increase decrease in contract with customer asset and liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is IDEAYA Biosciences, Inc.'s increase decrease in contract with customer asset and liabilities?
- IDEAYA Biosciences, Inc. (IDYA) reported increase decrease in contract with customer asset and liabilities of $1.49M in Q4 2025.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s increase decrease in contract with customer asset and liabilities?
- Over 2 years (2023 to 2025), IDEAYA Biosciences, Inc.'s increase decrease in contract with customer asset and liabilities has grown at a -34.1% compound annual growth rate (CAGR), from $13.75M to $5.97M.
- What does increase decrease in contract with customer asset and liabilities mean?
- This reflects the net change in contract assets and liabilities arising from the timing difference between revenue recognition and the receipt of cash from customers. An increase in contract liabilities typically indicates deferred revenue, while an increase in contract assets suggests revenue recognized in advance of billing. Monitoring this helps investors understand the company's working capital dynamics related to its specific revenue recognition cycles.